United Airlines sees profit below estimates as travel spending falls
The Chicago-based airline, however, said it has seen an improvement in overall bookings in the current quarter from a quarter ago, with a double-digit acceleration in business travel demand.
United expects an adjusted profit in the range of US$2.25 a share to US$2.75 per share in the quarter through September. The midpoint of the forecast is US$2.50 per share, compared with analysts' average estimate of US$2.60, according to LSEG data.
Its earnings in the third quarter are also expected to take a hit as a result of disruptions at Newark airport.
The company's full-year adjusted profit is now estimated to come in the range of US$9 a share to US$11 a share. That compares with analysts' expectations of US$10.04 a share.
The company's shares were down 2.5 per cent in after-hours trading.
In April, United took an unusual step of offering two different earnings forecasts as President Donald Trump's trade war dented consumer and business confidence, making it harder for carriers to forecast their business.
Since then, industry executives say travel demand has stabilized. Passenger traffic in the U.S., however, is still down from a year ago, leading to a decline in air fares, government data shows.
United said demand trends have improved since the beginning of July, thanks to less geopolitical and macroeconomic uncertainty.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Sun
19 minutes ago
- Toronto Sun
Coca-Cola says new cane sugar soda is coming to U.S. after Trump post
Published Jul 22, 2025 • 1 minute read Cleared cases of soft drinks sit on a shelf in a supermarket in Antwerp, Belgium, after Coca-Cola recalled some of its soft drinks in Europe, Tuesday, Jan. 28, 2025. Photo by Virginia Mayo / THE ASSOCIATED PRESS Coca-Cola Co. said it plans to launch a new Coke product made with U.S. cane sugar this fall. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account The announcement came less than a week after President Donald Trump said in a Truth Social post that the company agreed to use cane sugar in Coke beverages sold in the U.S. Coca-Cola also posted on Tuesday second-quarter sales growth and profit that beat Wall Street expectations as consumers continue to pay higher prices for the company's soft drinks. The shares were little changed at 7:25 a.m. in early New York trading. The stock has advanced 13% so far this year, outpacing the S&P 500 Index. For decades, Coca-Cola has used high fructose corn syrup, which is cheaper than cane sugar, to sweeten its signature product in the US. However, a pricier version of the soft drink that's sweetened with cane sugar and imported into the U.S. from Mexico has gained a cult following. Prior to the earnings release, CFRA analyst Arun Sundaram wrote that it's 'highly unlikely' that Coca-Cola would fully eliminate corn syrup from its lineup, adding that 'a more plausible outcome is the introduction of a new product line made with cane sugar, which would likely carry a higher cost and retail price.' Sunshine Girls Canada Sunshine Girls Columnists Celebrity
Toronto Sun
19 minutes ago
- Toronto Sun
GM profit falls as Trump tariffs add $1.1 billion in costs
Published Jul 22, 2025 • 2 minute read GMC trucks. Photo by Eric Thayer / Bloomberg General Motors Co.'s second-quarter profit fell as President Donald Trump's tariffs chopped $1.1 billion from adjusted earnings. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account The Detroit-based automaker said Tuesday it earned $2.53 per share on an adjusted basis, above the Bloomberg consensus forecast of $2.33 but short of the $3.06 it made a year ago. GM's profits also suffered from higher warranty costs and a buildup in inventory of electric vehicles. Net income declined 35% to $1.9 billion compared with $2.9 billion in the second quarter of last year. Shares of the carmaker fell 3.5% in premarket trading to $51.35 as of 7:20 a.m. in New York. The stock closed Monday almost unchanged for the year. GM's results showcase the difficulty automakers face to maintain profits in an environment that newly penalizes globally integrated parts supply chains and cross-border vehicle sales. Chief Executive Mary Barra hinted at that challenge in a letter to shareholders describing the carmaker's efforts to adjust to the new reality. Your noon-hour look at what's happening in Toronto and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. 'We are positioning the business for a profitable, long-term future as we adapt to new trade and tax policies, and a rapidly evolving tech landscape,' Barra said, noting an announcement in June to shift some production to the U.S. from Mexico. The company managed to beat Wall Street expectations as GM grew its U.S. vehicles sales in the the quarter despite higher tariffs. It achieved a second straight quarterly profit in China, which improved by $175 million over a year ago and helped on the bottom line. GM kept its current full-year forecast for earnings before interest and taxes in a range of $10 billion to $12.5 billion. The company had slashed its 2025 outlook in May, cutting it from initial projection in January for earning as much as $15.7 billion this year. This advertisement has not loaded yet, but your article continues below. Some non-tariff costs also hurt GM in the quarter. The company announced a recall of 600,000 trucks due to an engine defect, which contributed to $300 million in costs in the quarter. GM also worked to build up its electric vehicle inventory, which added $600 million in costs. Weaker pricing on fleet sales weighed on profits to the tune of $200 million. All told, earnings before interest and taxes in GM's North America business fell $2 billion in the quarter compared with the same period a year ago. Revenue fell 1.8% to $47.1 billion, partly from weaker pricing. The company indicated that year-on-year profit deceleration may not be as pronounced in the second half of the year. GM said it can offset one-third of its $4 billion to $5 billion in tariff exposure as more of its mitigation efforts begin to more fully take hold. Sunshine Girls Canada Sunshine Girls Columnists Celebrity
Globe and Mail
19 minutes ago
- Globe and Mail
Outlook Therapeutics Participates in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference
Video webcast now available on-demand ISELIN, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that Bob Jahr, newly appointed Chief Executive Officer, participated in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference. As part of the event, Mr. Jahr dove deeper into what brought him to Outlook Therapeutics, how he got to where he is today and provided insight into why he is excited about the future for Outlook Therapeutics. The on-demand video webcast is now available on as well as the Events page under the Investors section of the Company's website ( About Outlook Therapeutics, Inc. Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg; bevacizumab gamma) to enhance the standard of care for bevacizumab for the treatment of retina diseases. LYTENAVA™ (bevacizumab gamma) is the first ophthalmic formulation of bevacizumab to receive European Commission and MHRA Marketing Authorization for the treatment of wet AMD. Outlook Therapeutics commenced commercial launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK as a treatment for wet AMD. In the United States, ONS-5010/LYTENAVA™ (bevacizumab-vikg) is investigational, and a BLA has been resubmitted to the FDA. If approved in the United States, ONS-5010/LYTENAVA™, would be the first approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet AMD. Jenene Thomas
